Pre-Clinical Myocardial Metabolic Alterations in Chronic Kidney Disease | Zendy

Jeffrey C. Fink | Zendy; Martin A. Lodge | Zendy; Mark F. Smith | Zendy; Anish Hinduja | Zendy; Jeanine Brown | Zendy; Mara Y. Dinits-Pensy | Zendy; Vasken Dilsizian | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pre-Clinical Myocardial Metabolic Alterations in Chronic Kidney Disease

Author(s) -

Jeffrey C. Fink,

Martin A. Lodge,

Mark F. Smith,

Anish Hinduja,

Jeanine Brown,

Mara Y. Dinits-Pensy,

Vasken Dilsizian

Publication year - 2010

Publication title -

cardiology

Language(s) - English

Resource type - Journals

eISSN - 1421-9751

pISSN - 0008-6312

DOI - 10.1159/000318227

Subject(s) - renal function , medicine , kidney disease , nuclear medicine , creatinine , positron emission tomography , cardiology , chemistry

The risk for cardiovascular events conferred by decreased renal function is curvilinear with exponentially greater increases in risk as estimated glomerular filtration rate (eGFR) declines. In 13 non-diabetic pre-dialysis chronic kidney disease (CKD) patients, we employed quantitative F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) as a means to measure myocardial metabolic changes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research